Groups Debate Whether House Cannabis Bill Would Hinder FDA Oversight

By Beth Wang / July 31, 2020 at 7:27 PM
The House on Friday (July 31) passed 217-197 a fiscal 2021 funding bill containing a cannabis provision that one group argued would effectively prevent FDA from enforcing product safety standards. However, cannabis organizations say the group’s take on the provision is flawed because FDA, though it cannot regulate cannabis, can take action against cannabidiol companies, regardless of the amendment. At issue is an amendment House lawmakers voted Thursday evening (July 30) to include in a six-bill appropriations minibus that funds...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.